12:00 AM
Aug 19, 2013
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Selinexor: Phase Ib started

Karyopharm began an open-label, North American Phase Ib trial to evaluate tablet and capsule formulations of Selinexor in combination with high- and low-fat meals in...

Read the full 102 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >